The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
How acute promyelocytic leukaemia revived arsenic
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
Kakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
The tripartite motif family identifies cell compartments
Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2140 · Cited by 1,366
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
Self-citationde Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., & Dejean, A. (1991) · Cell · doi:10.1016/0092-8674(91)90113-d · Cited by 1,343
Self-citationMahajan, R., Delphin, C., Guan, T., Gerace, L., & Melchior, F. (1997) · Cell · doi:10.1016/s0092-8674(00)81862-0 · Cited by 1,256
Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
Soignet, S. L., Maslak, P., Wang, Z.-G., Jhanwar, S., Calleja, E., Dardashti, L. J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D. A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391901 · Cited by 1,213
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062
Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004
Chen, G., Zhu, J., Shi, X., Ni, J., Zhong, H., Si, G., Jin, X., Tang, W., Li, X., Xong, S., et al. (1996) · Blood · doi:10.1182/blood.v88.3.1052.1052 · Cited by 864
Self-citationIshov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T. H., Strauss, J. F., & Maul, G. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.221 · Cited by 832
The Nucleoporin RanBP2 Has SUMO1 E3 Ligase Activity
Pichler, A., Gast, A., Seeler, J. S., Dejean, A., & Melchior, F. (2002) · Cell · doi:10.1016/s0092-8674(01)00633-x · Cited by 816
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., & Evans, R. M. (1994) · Cell · doi:10.1016/0092-8674(94)90340-9 · Cited by 785
Chen, G., Shi, X., Tang, W., Xiong, S. M., Zhu, J., Cai, X., Han, Z., Ni, J.-H., Shi, G., Jia, P.-M., et al. (1997) · PubMed · Cited by 781
Self-citationWarrell, R. P., de The, H., Wang, Z.-Y., & Degos, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290307 · Cited by 776
He, L.-Z., Figueiredo-Pontes, L. L., Rego, E. M., & Pandolfi, P. P. (2015) · Encyclopedia of Cancer · doi:10.1007/978-3-662-46875-3_63 · Cited by 766
Sumo, ubiquitin's mysterious cousin
Müller, S., Hoege, C., Pyrowolakis, G., & Jentsch, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056591 · Cited by 764
Muller, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.61 · Cited by 674
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., & Dejean, A. (1994) · Cell · doi:10.1016/0092-8674(94)90341-7 · Cited by 652
Chen, Z., Brand, N. J., Chen, A., Chen, S. J., Tong, J. H., Wang, Z. Y., Waxman, S., & Zelent, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05757.x · Cited by 640
Self-citationMolecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17
Borrow, J., Goddard, A. D., Sheer, D., & Solomon, E. (1990) · Science · doi:10.1126/science.2218500 · Cited by 632
Grignani, F., Ferrucci, P. F., Testa, U., Talamo, G., Fagioli, M., Alcalay, M., Mencarelli, A., Grignani, F., Peschle, C., Nicoletti, I., et al. (1993) · Cell · doi:10.1016/0092-8674(93)80044-f · Cited by 583
The Role of PML in Tumor Suppression
Salomoni, P., & Pandolfi, P. P. (2002) · Cell · doi:10.1016/s0092-8674(02)00626-8 · Cited by 566
Role of SUMO-1–modified PML in nuclear body formation
Zhong, S., Müller, S., Ronchetti, S., Freemont, P. S., Dejean, A., & Pandolfi, P. P. (2000) · Blood · doi:10.1182/blood.v95.9.2748.009k31a_2748_2752 · Cited by 561
Pml is essential for multiple apoptotic pathways
Wang, Z.-G., Ruggero, D., Ronchetti, S., Zhong, S., Gaboli, M., Rivi, R., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/3073 · Cited by 558
He, L.-Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/ng0298-126 · Cited by 557
Role of PML in Cell Growth and the Retinoic Acid Pathway
Gang Wang, Z., Delva, L., Gaboli, M., Rivi, R., Giorgio, M., Cordon-Cardo, C., Grosveld, F., & Paolo Pandolfi, P. (1998) · Science · doi:10.1126/science.279.5356.1547 · Cited by 517
The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.
Koken, M. H., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., & Chomienne, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06356.x · Cited by 499
Lazo, G., Kantarjian, H., Estey, E., Thomas, D., O'Brien, S., & Cortes, J. (2003) · Cancer · doi:10.1002/cncr.11314 · Cited by 494
Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honoré, N., Doubeikovsky, A., Duprez, E., Pandolfi, P. P., Puvion, E., Freemont, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.12.1361 · Cited by 488
Self-citationThe function of PML in p53-dependent apoptosis
Guo, A., Salomoni, P., Luo, J., Shih, A., Zhong, S., Gu, W., & Paolo Pandolfi, P. (2000) · Nature Cell Biology · doi:10.1038/35036365 · Cited by 472
A PMLRAR α transgene initiates murine acute promyelocytic leukemia
Brown, D., Kogan, S., Lagasse, E., Weissman, I., Alcalay, M., Pelicci, P. G., Atwater, S., & Bishop, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2551 · Cited by 434
Zhu, J., Koken, M. H. M., Quignon, F., Chelbi-Alix, M. K., Degos, L., Wang, Z. Y., Chen, Z., & de Thé, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3978 · Cited by 427
Self-citationvom Baur, E., Zechel, C., Heery, D., Heine, M. J., Garnier, J. M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P., & Losson, R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00339.x · Cited by 399
Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes.
de The, H., Marchio, A., Tiollais, P., & Dejean, A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03394.x · Cited by 394
PML induces a novel caspase-independent death process
Quignon, F., De Bels, F., Koken, M., Feunteun, J., Ameisen, J.-C., & de Thé, H. (1998) · Nature Genetics · doi:10.1038/3068 · Cited by 374
Self-citationZhu, J., Gianni, M., Kopf, E., Honoré, N., Chelbi-Alix, M., Koken, M., Quignon, F., Rochette-Egly, C., & de Thé, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14807 · Cited by 372
Self-citationRegulation of p53 activity in nuclear bodies by a specific PML isoform
Fogal, V. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6185 · Cited by 372
Shao, W., Fanelli, M., Ferrara, F. F., Riccioni, R., Rosenauer, A., Davison, K., Lamph, W. W., Waxman, S., Pelicci, P. G., Lo Coco, F., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.2.124 · Cited by 344
Licht, J., Chomienne, C., Goy, A., Chen, A., Scott, A., Head, D., Michaux, J., Wu, Y., DeBlasio, A., & Miller, W. J. (1995) · Blood · doi:10.1182/blood.v85.4.1083.bloodjournal8541083 · Cited by 343
Altucci, L., Rossin, A., Raffelsberger, W., Reitmair, A., Chomienne, C., & Gronemeyer, H. (2001) · Nature Medicine · doi:10.1038/89050 · Cited by 340
Hong, S.-H., David, G., Wong, C.-W., Dejean, A., & Privalsky, M. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9028 · Cited by 340
Acute leukemia with promyelocytic features in PML/RARα transgenic mice
He, L.-Z., Tribioli, C., Rivi, R., Peruzzi, D., Pelicci, P. G., Soares, V., Cattoretti, G., & Pandolfi, P. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5302 · Cited by 339
Chen, C.-L., Liu, Q., Pui, C.-H., Rivera, G. K., Sandlund, J. T., Ribeiro, R., Evans, W. E., & Relling, M. V. (1997) · Blood · doi:10.1182/blood.v89.5.1701 · Cited by 314
Rochette-Egly, C., Adam, S., Rossignol, M., Egly, J.-M., & Chambon, P. (1997) · Cell · doi:10.1016/s0092-8674(00)80317-7 · Cited by 308
Lallemand-Breitenbach, V., Guillemin, M.-C., Janin, A., Daniel, M.-T., Degos, L., Kogan, S. C., Michael Bishop, J., & de Thé, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1043 · Cited by 305
Self-citationHe, L.-Z., Tolentino, T., Grayson, P., Zhong, S., Warrell, R. P., Rifkind, R. A., Marks, P. A., Richon, V. M., & Pandolfi, P. P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11537 · Cited by 303
PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.
Perez, A., Kastner, P., Sethi, S., Lutz, Y., Reibel, C., & Chambon, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05986.x · Cited by 292
PML, a growth suppressor disrupted in acute promyelocytic leukemia.
Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, G., & Chang, K. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6858 · Cited by 288
Oligomerization of RAR and AML1 Transcription Factors as a Novel Mechanism of Oncogenic Activation
Minucci, S., Maccarana, M., Cioce, M., De Luca, P., Gelmetti, V., Segalla, S., Di Croce, L., Giavara, S., Matteucci, C., Gobbi, A., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80321-4 · Cited by 285
Regulation and Localization of the Bloom Syndrome Protein in Response to DNA Damage
Bischof, O., Kim, S.-H., Irving, J., Beresten, S., Ellis, N. A., & Campisi, J. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.2.367 · Cited by 269
PML protein expression in hematopoietic and acute promyelocytic leukemia cells
Daniel, M., Koken, M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M., Degos, L., Chomienne, C., & de The, H. (1993) · Blood · doi:10.1182/blood.v82.6.1858.1858 · Cited by 251
Liu, T.-X., Zhang, J.-W., Tao, J., Zhang, R.-B., Zhang, Q.-H., Zhao, C.-J., Tong, J.-H., Lanotte, M., Waxman, S., Chen, S.-J., et al. (2000) · Blood · doi:10.1182/blood.v96.4.1496 · Cited by 238
Self-citationThe paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects
Bode, A. M., & Dong, Z. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00215-3 · Cited by 238
Lin, R. J., & Evans, R. M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80322-6 · Cited by 232
The PML growth-suppressor has an altered expression in human oncogenesis.
Koken, M. H. M., Linares‐Cruz, G., Quignon, F., Viron, A., Chelbi‐Alix, M. K., Sobczak‐Thépot, J., Juhlin, L., Degos, L., Calvo, F. M., & de Thé, H. (1995) · PubMed · Cited by 231
Yoshida, H., Kitamura, K., Tanaka, K., Ōmura, S., Miyazaki, T., Hachiya, T., Ohno, R., & Naoe, T. (1996) · PubMed · Cited by 217
Wu, G., Lee, W.-H., & Chen, P.-L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000390200 · Cited by 209
Jing, Y., Wang, L., Xia, L., Chen, G.-Q., Chen, Z., Miller, W. H., & Waxman, S. (2001) · Blood · doi:10.1182/blood.v97.1.264 · Cited by 204
Self-citationArsenic Enhancement of Skin Neoplasia by Chronic Stimulation of Growth Factors
Germolec, D. R., Spalding, J., Yu, H.-S., Chen, G. S., Simeonova, P. P., Humble, M. C., Bruccoleri, A., Boorman, G. A., Foley, J. F., Yoshida, T., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65692-1 · Cited by 200
Raelson, J., Nervi, C., Rosenauer, A., Benedetti, L., Monczak, Y., Pearson, M., Pelicci, P., & Miller, W. J. (1996) · Blood · doi:10.1182/blood.v88.8.2826.bloodjournal8882826 · Cited by 197
Rego, E. M., He, L.-Z., Warrell, R. P., Wang, Z.-G., & Pandolfi, P. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180290497 · Cited by 194
Bazarbachi, A., El-Sabban, M. E., Nasr, R., Quignon, F., Awaraji, C., Kersual, J., Dianoux, L., Zermati, Y., Haidar, J. H., Hermine, O., et al. (1999) · Blood · doi:10.1182/blood.v93.1.278 · Cited by 179
Camacho, L. H., Soignet, S. L., Chanel, S., Ho, R., Heller, G., Scheinberg, D. A., Ellison, R., & Warrell, R. P. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2620 · Cited by 174
Grobelny, J. V., Godwin, A. K., & Broccoli, D. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.24.4577 · Cited by 165
Zhu, J., Lallemand-Breitenbach, V., & de Thé, H. (2001) · Oncogene · doi:10.1038/sj.onc.1204852 · Cited by 164
Self-citationPML nuclear bodies are general targets for inflammation and cell proliferation.
Terris, B., Baldin, V., Dubois, S., Degott, C., Fléjou, J., Hénin, D., & Dejean, A. (1995) · PubMed · Cited by 163
Giannì, M., Bauer, A., Garattini, E., Chambon, P., & Rochette‐Egly, C. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf374 · Cited by 151
Shao, W., Benedetti, L., Lamph, W. W., Nervi, C., & Miller, W. H. (1997) · Blood · doi:10.1182/blood.v89.12.4282 · Cited by 146
El-Sabban, M. E., Nasr, R., Dbaibo, G. S., Hermine, O., Abboushi, N., Quignon, F., Ameisen, J., Bex, F., de Thé, H., & Bazarbachi, A. A. (2000) · PubMed · doi:10.1182/blood.v96.8.2849 · Cited by 139
Positive and negative regulation of granulopoiesis by endogenous RARα
Kastner, P., Lawrence, H. J., Waltzinger, C., Ghyselinck, N. B., Chambon, P., & Chan, S. H. (2001) · Blood · doi:10.1182/blood.v97.5.1314 · Cited by 135
Arsenic inhibition of telomerase transcription leads to genetic instability
Chou, W., Hawkins, A. L., Barrett, J. F., Griffin, C. A., & Dang, C. V. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14064 · Cited by 133
Arsenic and Mercury in Traditional Chinese Herbal Balls
Espinoza, E. O., Mann, M.-J., & Bleasdell, B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509213331217 · Cited by 132
Active repression of RAR signaling is required for head formationPreprint
Koide, T., Downes, M., Chandraratna, R. A. S., Blumberg, B., & Umesono, K. (2001) · Genes & Development · doi:10.1101/gad.908801 · Cited by 128
Nijmegen Breakage Syndrome disease protein and Mre11 at PML Nuclear Bodies and meiotic telomeres
Lombard, D. B. (2001) · Springer eBooks · doi:10.1007/978-1-4615-1405-3_4 · Cited by 120
Regulation of Pax3 transcriptional activity by SUMO-1-modified PML
Lehembre, F., Müller, S. P., Pandolfi, P. P., & Dejean, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204063 · Cited by 118
Kogan, S. C., Brown, D. E., Shultz, D. B., Truong, B.-T., Lallemand-Breitenbach, V., Guillemin, M.-C., Lagasse, E., Weissman, I. L., & Bishop, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.531 · Cited by 108
Self-citationDu, C., Redner, R. L., Cooke, M. P., & Lavau, C. (1999) · Blood · doi:10.1182/blood.v94.2.793 · Cited by 102
Koken, M. H. M., Daniel, M., Gianni’, M., Zelent, A., Licht, J. D., Buzyn, A., Minard, P., Degos, L., Varet, B. R., & de Thé, H. (1999) · Oncogene · doi:10.1038/sj.onc.1202414 · Cited by 100
Kogan, S. C., Hong, S.-H., Shultz, D. B., Privalsky, M. L., & Bishop, J. M. (2000) · Blood · doi:10.1182/blood.v95.5.1541.005k28_1541_1550 · Cited by 97
Baumann, C. T., Ma, H., Wolford, R. G., Reyes, J. C., Maruvada, P., Lim, C. S., Yen, P. M., Stallcup, M. R., & Hager, G. L. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.4.0618 · Cited by 97
Transcriptional regulation: Kamikaze activators
Thomas, D., & Tyers, M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00462-0 · Cited by 94
Arsenic Trioxide, a Novel Mitochondriotoxic Anticancer Agent?
Kroemer, G., & de Thé, H. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.9.743 · Cited by 89
Zhu, Q., Zhang, J., Zhu, H., Shen, Y., Flexor, M., Jia, P.-M., Yu, Y., Cai, X., Waxman, S., Lanotte, M., et al. (2002) · Blood · doi:10.1182/blood.v99.3.1014 · Cited by 88
Self-citationJansen, J. H., Mahfoudi, A., Rambaud, S., Lavau, C., Wahli, W., & Dejean, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7401 · Cited by 86
Fabunmi, R. P., Wigley, W. C., Thomas, P., & Demartino, G. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.1.29 · Cited by 86
Jansen, J. H., Ridder, M. C. B.-D., Geertsma-Kleinekoort, W. M. C., Erpelinck-Verschueren, C. A. J., van Lom, K., Smit, E. M. E., Slater, R. M., Reijden, B. A. V., de Greef, G. E., Sonneveld, P., et al. (1999) · Blood · doi:10.1182/blood.v94.1.39.413a26_39_45 · Cited by 83
Beau, M. M. L., Bitts, S. M., Davis, E. M., & Kogan, S. C. (2002) · Blood · doi:10.1182/blood.v99.8.2985 · Cited by 82
Is the Human Carcinogen Arsenic Carcinogenic to Laboratory Animals?
Huff, J. E. (2000) · Toxicological Sciences · doi:10.1093/toxsci/55.1.17 · Cited by 75
P53 and PML: new partners in tumor suppression
Gottifredi, V., & Prives, C. L. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)01983-3 · Cited by 71
Petti, M. C., Fazi, F., Gentile, M., Diverio, D., de Fabritiis, P., Propris, M. S. D., Fiorini, R., Spiriti, M. A. A., Padula, F., Pelicci, P. G., et al. (2002) · Blood · doi:10.1182/blood-2001-12-0368 · Cited by 67
Kinjo, K., Kizaki, M., Muto, A., Fukuchi, Y., Umezawa, A., Yamato, K., Nishihara, T., Hata, J., Ito, M., Ueyama, Y., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401646 · Cited by 63
Lineage restriction of the RARalpha gene expression in myeloid differentiation
Zhu, J., Heyworth, C. M., Glasow, A., Huang, Q. H., Petrie, K., Lanotte, M., Benoit, G., Gallagher, R., Waxman, S., Enver, T., et al. (2001) · Blood · doi:10.1182/blood.v98.8.2563 · Cited by 61
Self-citationHong, S.-H., Yang, Z., & Privalsky, M. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.21.7172-7182.2001 · Cited by 59
Muto, A., Kizaki, M., Kawamura, C., Matsushita, H., Fukuchi, Y., Umezawa, A., Yamada, T., Hata, J., Hozumi, N., Yamato, K., et al. (2001) · Leukemia · doi:10.1038/sj.leu.2402162 · Cited by 42
Johnson, B. S., Mueller, L., Si, J., & Collins, S. J. (2002) · Blood · doi:10.1182/blood.v99.3.746 · Cited by 38
Gu, B.-W., Xiong, H., Zhou, Y., Chen, B., Wang, L., Dong, S., Yu, Z., Lu, L.-F., Zhong, M., Yin, H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112194799 · Cited by 38
Self-citationQuenech’Du, N., Ruchaud, S., Khelef, N., Guiso, N., & Lanotte, M. (1998) · Leukemia · doi:10.1038/sj.leu.2401171 · Cited by 38
Jing, Y., Xia, L., & Waxman, S. (2002) · Blood · doi:10.1182/blood.v100.3.1008 · Cited by 34
Merghoub, T., Gurrieri, C., Piazza, F., & Pandolfi, P. P. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0385 · Cited by 17
Alpert, M. I. (2001) · Scientific American · doi:10.1038/scientificamerican0601-20 · Cited by 4
Cited by
Targeting Apoptosis Pathways in Cancer Therapy
Ghobrial, I. M., Witzig, T. E., & Adjei, A. A. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.3.178 · Cited by 1,330
Acute promyelocytic leukemia: from highly fatal to highly curable
Wang, Z.-Y., & Chen, Z. (2008) · Blood · doi:10.1182/blood-2007-07-102798 · Cited by 1,277
Self-citationAcute and chronic arsenic toxicity
Ratnaike, R. N. (2003) · Postgraduate Medical Journal · doi:10.1136/pmj.79.933.391 · Cited by 1,175
Nuclear structure in cancer cells
Zink, D., Fischer, A. H., & Nickerson, J. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1430 · Cited by 1,068
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease
Valko, M., Jomova, K., Rhodes, C. J., Kuča, K., & Musílek, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1579-5 · Cited by 1,022
Metadata
- Authors
- Zhu, J., Chen, Z., Lallemand-Breitenbach, V., & de Thé, H.
- Venue
- Nature Reviews Cancer
- Published
- 2002-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 705-714
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1541929695
- Cited by
- 321
- References
- 101
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.